Updates are available Correction dated 2024-12-31
Click to view Correction: https://doi.org/10.1186/s12986-024-00878-w
-
Authors
Mullins, Veronica Anne
Snider, Justin M.
Michael, Bryce
Porter, Lydia Rose
Brinton, Roberta Diaz
Chilton, Floyd H.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AT008621)
U.S. Department of Agriculture (ARZT-1361680-H23-157)
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 18 June 2024
First Online: 8 July 2024
Change Date: 31 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12986-024-00878-w
Declarations
:
: Data collection methods were reported previously (Mullins, 2022). All procedures involving human subjects were approved by the institutional review board of the University of Arizona for the use of human subjects in research (protocol 1904553365). Procedures were conducted in full accordance with the Declaration of Helsinki guidelines.
: Not applicable.
: F.H.C. is a cofounder of Resonance Pharma Inc.
